<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" dstore:dataset="idrccrdi-act-2016-6" dstore:index="245" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:dstore="http://d-portal.org/xmlns/dstore" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-109554-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Validation des tests mol&#xE9;culaires rapides de d&#xE9;tection de la COVID-19 et int&#xE9;gration avec les diagnostics de la tuberculose</narrative>
   <narrative xml:lang="EN">Validation of rapid molecular testing for COVID-19 and integration with tuberculosis diagnostics</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">La pand&#xE9;mie de COVID-19 provoque une forte morbidit&#xE9; au P&#xE9;rou et dans d&#x2019;autres pays d&#x2019;Am&#xE9;rique latine et nuit &#xE0; la capacit&#xE9; des services de sant&#xE9; &#xE0; fournir des soins appropri&#xE9;s aux personnes atteintes de maladies n&#xE9;glig&#xE9;es, mais qui persistent &#xE0; l&#x2019;abri des projecteurs de l&#x2019;actualit&#xE9; mondiale. Sur le continent am&#xE9;ricain, le P&#xE9;rou est le deuxi&#xE8;me pays le plus touch&#xE9; par la tuberculose (TB) apr&#xE8;s le Br&#xE9;sil. &#xC9;tant donn&#xE9; que les sympt&#xF4;mes de la COVID-19 et de la tuberculose se ressemblent, l&#x2019;int&#xE9;gration des tests de la COVID-19 et de la tuberculose serait l&#x2019;occasion d&#x2019;am&#xE9;liorer la qualit&#xE9; des soins aux patients. 

Cette &#xE9;tude tirera parti de l&#x2019;infrastructure existante pour le diagnostic de la tuberculose au P&#xE9;rou &#x2014; qui fournit des tests mol&#xE9;culaires de d&#xE9;pistage de la tuberculose peu co&#xFB;teux, simples, rapides et automatis&#xE9;s &#x2014; pour valider son utilisation pour le diagnostic de la COVID-19 chez les adultes suspect&#xE9;s d&#x2019;&#xEA;tre infect&#xE9;s par cette maladie &#xE0; Lima. Elle &#xE9;valuera l&#x2019;int&#xE9;gration des deux diagnostics en utilisant un seul &#xE9;chantillon respiratoire dans un h&#xF4;pital secondaire d&#x2019;une r&#xE9;gion &#xE0; forte pr&#xE9;valence de tuberculose en dehors de Lima. Le renforcement de la capacit&#xE9; de diagnostic de la COVID-19 et son int&#xE9;gration au d&#xE9;pistage de la tuberculose permettront d&#x2019;&#xE9;conomiser des ressources, d&#x2019;am&#xE9;liorer la qualit&#xE9; des soins et de r&#xE9;duire le temps d&#x2019;attente des r&#xE9;sultats.

Le projet a &#xE9;t&#xE9; s&#xE9;lectionn&#xE9; pour un financement dans le cadre de la Possibilit&#xE9; de financement pour une intervention de recherche rapide relative &#xE0; la COVID-19 en mai 2020, coordonn&#xE9; par les Instituts de recherche en sant&#xE9; du Canada en partenariat avec le CRDI et plusieurs autres organismes de financement de la recherche en sant&#xE9; au Canada.</narrative>
   <narrative xml:lang="EN">The COVID-19 pandemic is causing a high burden of disease in Peru and other Latin American countries and affecting the capacity of health services to provide appropriate care to neglected diseases that persist outside the global spotlight. In the Americas, Peru is second only to Brazil in total cases of tuberculosis (TB). Considering that the symptoms of COVID-19 and TB are similar, integrating COVID-19 and TB testing would be an opportunity to improve the quality of patient care. 

This study will take advantage of existing infrastructure for TB diagnosis in Peru &#x2014; which provides cheap, user-friendly, and rapid, automated molecular TB testing &#x2014; to validate its use for the diagnosis of COVID-19 in adults with suspected COVID-19 infection in Lima. It will assess the integration of the two diagnoses using a single respiratory sample at a secondary hospital in an area of high prevalence of TB outside of Lima. Strengthening COVID-19 diagnostic capacity and integrating COVID-19 with TB testing will save resources, improve quality of disease care, and minimize transmission time in the community.

This project was selected for funding through the COVID-19 May 2020 Rapid Research Funding Opportunity, coordinated by the Canadian Institutes of Health Research in partnership with IDRC and several other health research funding agencies across Canada.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="80">
   <narrative xml:lang="FR">Institut de recherche du centre universitaire de sant&#xE9; McGill</narrative>
   <narrative xml:lang="EN">Research Institute of the McGill University Health Centre</narrative>
  </participating-org>
  <participating-org role="4" type="80">
   <narrative xml:lang="FR">Institut de recherche du centre universitaire de sant&#xE9; McGill</narrative>
   <narrative xml:lang="EN">Research Institute of the McGill University Health Centre</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-08-01" type="2"></activity-date>
  <activity-date iso-date="2021-08-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="PE" percentage="100"></recipient-country>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-07-09"></transaction-date>
   <value currency="CAD" value-date="2020-07-09">421479</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherche du centre universitaire de sant&#xE9; McGill</narrative>
    <narrative xml:lang="EN">Research Institute of the McGill University Health Centre</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-07-10"></transaction-date>
   <value currency="CAD" value-date="2020-07-10">400404</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherche du centre universitaire de sant&#xE9; McGill</narrative>
    <narrative xml:lang="EN">Research Institute of the McGill University Health Centre</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-07-31"></transaction-date>
   <value currency="CAD" value-date="2020-07-31">-400404</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherche du centre universitaire de sant&#xE9; McGill</narrative>
    <narrative xml:lang="EN">Research Institute of the McGill University Health Centre</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-07-31"></transaction-date>
   <value currency="CAD" value-date="2020-07-31">400404</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherche du centre universitaire de sant&#xE9; McGill</narrative>
    <narrative xml:lang="EN">Research Institute of the McGill University Health Centre</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
